Treatment with Vitamin B3 Improves Functional Recovery and Reduces GFAP Expression following Traumatic Brain Injury in Rats

Michael R. Hoane, Stacy L. Akstulewicz, James Toppen

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Previous studies have shown that administration of vitamin B3 (B3) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery. The present study evaluated the effect of administration of B3 on recovery of function following traumatic brain injury (TBI), incorporating the bilateral medial frontal cortex contusion injury model. Groups of rats were assigned to B3 (500 mg/kg) or saline (1.0 ml/kg) treatment conditions and received contusion injuries or sham surgeries. Drug treatment was administered 15 min and 24 h following injury. Rats were examined on a variety of tests to measure sensorimotor performance (bilateral tactile adhesive removal), skilled forelimb use (staircase test), and cognitive ability (reference and working memory) in the Morris Water Maze. Administration of B3 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test, but not on skilled forelimb use. The acquisition of reference and working memory tests were also significantly improved compared to saline-treated rats. Examination of the brains revealed that administration of B3 significantly reduced the size of the lesion compared to treatment with saline. In addition, examination of glial fibrillary acidic protein (GFAP) expression around the lesion revealed that B3 significantly reduced the number of GFAP+ astrocytes. These results indicate that B3 administration significantly improved behavioral outcome following injury, reduced the size of the lesion, and reduced the expression of GFAP. The current findings suggest that B3 may have therapeutic potential for the treatment of TBI.

Original languageEnglish (US)
Pages (from-to)1189-1199
Number of pages11
JournalJournal of Neurotrauma
Volume20
Issue number11
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Niacinamide
Glial Fibrillary Acidic Protein
Wounds and Injuries
Forelimb
Contusions
Touch
Short-Term Memory
Aptitude
Recovery of Function
Frontal Lobe
Astrocytes
Adhesives
Infarction
Ischemia
Animal Models
Traumatic Brain Injury
Water
Brain
Pharmaceutical Preparations

Keywords

  • GFAP
  • Niacin
  • Nicotinamide
  • Rat
  • Recovery of function
  • Vitamin B

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Treatment with Vitamin B3 Improves Functional Recovery and Reduces GFAP Expression following Traumatic Brain Injury in Rats. / Hoane, Michael R.; Akstulewicz, Stacy L.; Toppen, James.

In: Journal of Neurotrauma, Vol. 20, No. 11, 01.01.2003, p. 1189-1199.

Research output: Contribution to journalArticle

@article{d4dd703ea02d473489ef1ae577739b9f,
title = "Treatment with Vitamin B3 Improves Functional Recovery and Reduces GFAP Expression following Traumatic Brain Injury in Rats",
abstract = "Previous studies have shown that administration of vitamin B3 (B3) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery. The present study evaluated the effect of administration of B3 on recovery of function following traumatic brain injury (TBI), incorporating the bilateral medial frontal cortex contusion injury model. Groups of rats were assigned to B3 (500 mg/kg) or saline (1.0 ml/kg) treatment conditions and received contusion injuries or sham surgeries. Drug treatment was administered 15 min and 24 h following injury. Rats were examined on a variety of tests to measure sensorimotor performance (bilateral tactile adhesive removal), skilled forelimb use (staircase test), and cognitive ability (reference and working memory) in the Morris Water Maze. Administration of B3 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test, but not on skilled forelimb use. The acquisition of reference and working memory tests were also significantly improved compared to saline-treated rats. Examination of the brains revealed that administration of B3 significantly reduced the size of the lesion compared to treatment with saline. In addition, examination of glial fibrillary acidic protein (GFAP) expression around the lesion revealed that B3 significantly reduced the number of GFAP+ astrocytes. These results indicate that B3 administration significantly improved behavioral outcome following injury, reduced the size of the lesion, and reduced the expression of GFAP. The current findings suggest that B3 may have therapeutic potential for the treatment of TBI.",
keywords = "GFAP, Niacin, Nicotinamide, Rat, Recovery of function, Vitamin B",
author = "Hoane, {Michael R.} and Akstulewicz, {Stacy L.} and James Toppen",
year = "2003",
month = "1",
day = "1",
doi = "10.1089/089771503770802871",
language = "English (US)",
volume = "20",
pages = "1189--1199",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Treatment with Vitamin B3 Improves Functional Recovery and Reduces GFAP Expression following Traumatic Brain Injury in Rats

AU - Hoane, Michael R.

AU - Akstulewicz, Stacy L.

AU - Toppen, James

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Previous studies have shown that administration of vitamin B3 (B3) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery. The present study evaluated the effect of administration of B3 on recovery of function following traumatic brain injury (TBI), incorporating the bilateral medial frontal cortex contusion injury model. Groups of rats were assigned to B3 (500 mg/kg) or saline (1.0 ml/kg) treatment conditions and received contusion injuries or sham surgeries. Drug treatment was administered 15 min and 24 h following injury. Rats were examined on a variety of tests to measure sensorimotor performance (bilateral tactile adhesive removal), skilled forelimb use (staircase test), and cognitive ability (reference and working memory) in the Morris Water Maze. Administration of B3 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test, but not on skilled forelimb use. The acquisition of reference and working memory tests were also significantly improved compared to saline-treated rats. Examination of the brains revealed that administration of B3 significantly reduced the size of the lesion compared to treatment with saline. In addition, examination of glial fibrillary acidic protein (GFAP) expression around the lesion revealed that B3 significantly reduced the number of GFAP+ astrocytes. These results indicate that B3 administration significantly improved behavioral outcome following injury, reduced the size of the lesion, and reduced the expression of GFAP. The current findings suggest that B3 may have therapeutic potential for the treatment of TBI.

AB - Previous studies have shown that administration of vitamin B3 (B3) in animal models of ischemia significantly reduced the size of infarction and improved functional recovery. The present study evaluated the effect of administration of B3 on recovery of function following traumatic brain injury (TBI), incorporating the bilateral medial frontal cortex contusion injury model. Groups of rats were assigned to B3 (500 mg/kg) or saline (1.0 ml/kg) treatment conditions and received contusion injuries or sham surgeries. Drug treatment was administered 15 min and 24 h following injury. Rats were examined on a variety of tests to measure sensorimotor performance (bilateral tactile adhesive removal), skilled forelimb use (staircase test), and cognitive ability (reference and working memory) in the Morris Water Maze. Administration of B3 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test, but not on skilled forelimb use. The acquisition of reference and working memory tests were also significantly improved compared to saline-treated rats. Examination of the brains revealed that administration of B3 significantly reduced the size of the lesion compared to treatment with saline. In addition, examination of glial fibrillary acidic protein (GFAP) expression around the lesion revealed that B3 significantly reduced the number of GFAP+ astrocytes. These results indicate that B3 administration significantly improved behavioral outcome following injury, reduced the size of the lesion, and reduced the expression of GFAP. The current findings suggest that B3 may have therapeutic potential for the treatment of TBI.

KW - GFAP

KW - Niacin

KW - Nicotinamide

KW - Rat

KW - Recovery of function

KW - Vitamin B

UR - http://www.scopus.com/inward/record.url?scp=0344153780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344153780&partnerID=8YFLogxK

U2 - 10.1089/089771503770802871

DO - 10.1089/089771503770802871

M3 - Article

VL - 20

SP - 1189

EP - 1199

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 11

ER -